Related Experiment Video
Updated: May 5, 2026

Echocardiographic Assessment of the Right Heart in Mice
Published on: November 27, 2013
Hank the Heart and Animation-Based Education for Pulmonary Hypertension
Michelle Cash1, Barbara Giambra2,3,4,5, Lara Stone6
1Heart Institute, Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA.
Health education animation for pediatric pulmonary hypertension (PH) was well-received but insufficient. Patients and families connected with relatable content, emphasizing the need for personalized, ongoing educational support.
Area of Science:
- Pediatric Health
- Medical Education
- Health Literacy
Background:
- Pulmonary hypertension (PH) is a rare, complex condition impacting children and adults.
- Effective health education is crucial for patient and caregiver decision-making.
- Understanding patient and family perceptions of educational tools is vital.
Purpose of the Study:
- To assess patient and family perceptions of the "Hank the Heart" animation for health literacy.
- To identify preferred learning methods for future pediatric pulmonary hypertension education.
Main Methods:
- A qualitative study utilizing focus groups with patients and family caregivers.
- Inductive thematic analysis of focus group and interview transcripts.
Main Results:
- The "Hank the Heart" animation was perceived as helpful but not comprehensive for educational needs.
- Patients and families strongly identified with the animated character and its representation of their experiences.
- A need for personalized, ongoing, and tailored patient and family education was identified.
Conclusions:
- Animation videos are a well-received educational modality for pediatric pulmonary hypertension.
- Patient and family feedback provides valuable insights for improving future educational animation development.
- Tailored, patient-centered education is essential for addressing complex health and learning needs.
More Related Videos
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Heart Failure II: Pathophysiology
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Cardiomyopathy III: Hypertrophic Cardiomyopathy

